LDL Cholesterol Management: Protecting Your Heart, Brain, and Long-Term Health

Why Managing LDL-C Matters

Low-density lipoprotein cholesterol (LDL-C), often called "bad cholesterol," plays a central role in the development of atherosclerotic cardiovascular disease (ASCVD), including heart attacks, strokes, and peripheral artery disease. Over time, elevated LDL-C contributes to plaque buildup inside arteries, increasing the risk of life-threatening cardiovascular events.

Managing LDL-C is not simply about improving a cholesterol number — it is about reducing lifetime exposure to harmful cholesterol particles and protecting overall health.

Current LDL-C Guidelines

The 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia emphasizes earlier identification of risk, personalized treatment, and achieving appropriate LDL-C goals based on cardiovascular risk.

General LDL-C goals include:

• Lower-risk individuals: LDL-C goal may be <100 mg/dL depending on overall risk assessment
• High-risk individuals: LDL-C goal of <70 mg/dL is recommended
• Very high-risk patients with established ASCVD: LDL-C goal of <55 mg/dL is recommended for secondary prevention

Why LDL-C Control Is Important

Elevated LDL-C increases the risk of heart attacks caused by blocked coronary arteries, stroke from vascular disease affecting the brain, peripheral artery disease affecting circulation, and progression of atherosclerosis throughout the body. Reducing LDL-C lowers cardiovascular risk and is one of the most effective strategies for preventing complications and extending healthy years of life.

Treatment Options for LDL-C Reduction

Lifestyle Optimization

Lifestyle changes remain the foundation of cholesterol management: follow a heart-healthy diet rich in vegetables, fruits, whole grains, legumes, and lean proteins; reduce saturated fats and avoid trans fats; maintain a healthy weight; exercise regularly; avoid tobacco products; and manage blood pressure, diabetes, and other cardiovascular risk factors.

Statin Therapy

Statins remain the foundation of LDL-C lowering therapy because of their strong evidence in reducing heart attacks, strokes, and cardiovascular deaths. Examples include atorvastatin, rosuvastatin, simvastatin, and pravastatin. The intensity of statin therapy is individualized based on cardiovascular risk and LDL-C goals.

Additional LDL-C Lowering Therapies

For patients who do not achieve LDL-C goals with statins alone or who cannot tolerate statins, additional therapies may include:

• Ezetimibe: Reduces intestinal cholesterol absorption and can be added to statin therapy
• PCSK9 inhibitors: Injectable medications that provide substantial LDL-C reduction for selected high-risk patients
• Bempedoic acid: An oral medication option for additional LDL-C lowering, including patients with statin intolerance
• Inclisiran: A therapy that reduces PCSK9 production and lowers LDL-C with infrequent maintenance dosing

Diabetes and Cholesterol: A Critical Connection

People with diabetes have a higher risk of cardiovascular disease. The ADA Standards of Care in Diabetes — 2026 recommends statin therapy for many adults with diabetes and more intensive LDL-C lowering for those with additional cardiovascular risk factors or established ASCVD.

Take Control of Your Cholesterol Health

LDL-C management is a lifelong commitment to protecting your heart, brain, blood vessels, and overall health. Early identification of risk factors, healthy lifestyle choices, and appropriate medical therapy can significantly reduce the risk of cardiovascular disease.

Know your LDL-C level. Understand your cardiovascular risk. Work with your healthcare team to create a personalized plan to protect your future health. We can help you get to a healthier YOU!